Latest News & Events
Nov, 2022
Nexomics was awarded the CATALYST RESEARCH AND DEVELOPMENT VOUCHER PILOT PROGRAM grant by NEW JERSEY COMMISSION ON SCIENCE, INNOVATION AND TECHNOLOGY
Jul 1, 2021
Nexomics Introduces New Magegement Team: Dr. Rong Xiao as CSO and Dr. Gaohua Liu as CEO
Read moreJune 24, 2021
Nexomics Founder Prof. G. Montelione, CSO Dr. Gaohua Liu and their Colleagues have identified the design principles for creating large “ideal” proteins from scratch, paving the way for the design of proteins with new biochemical functions. The results were published today in Nature Communications.
Read moreApr 21, 2020
Nexomics Founder Prof. G. Montelione and His Colleagues Propose Using HCV Protease Inhibitor Drugs to Inhibit SARS-COV Virus in Recent Paper
Read moreApr 2, 2020
Nexomics Scientist Dr. Mark Pinkerton Awarded with The New Jersey Innovation and Research Fellowship
Read moreMay 9, 2019
Prof. Masayori Inouye, Nexomics Scientific Advisor, Elected as New Member of the National Academy of Sciences
Read moreMar 13, 2018
Janssen and Nexomics Scientists Report Highly Dynamic Picture of the Inhibitor Bound Dengue NS2B-NS3pro
Read moreOct 30, 2017
Prof. John Hunt, Columbia University, and Prof. Masayori Inouye, Rutgers University, Welcomed as Founding Members of the Nexomics Scientific Advisory Board (SAB)
Read moreJul 1, 2016
Nexomics Introduces New Magegement Team: Dr. Rong Xiao as CEO and Dr. Gaohua Liu as CSO
Read moreJan 28, 2014
Cambridge Isotope Laboratories and Nexomics Biosciences Signed an Exclusive Worldwide Commercial Supply Agreement
Read more